News Deal finally unlocks NHS access to ITF's Duchenne drug After nearly two years of wrangling, ITF's Duvyzat can be used by the NHS to treat people living with Duchenne muscular dystrophy.
News FDA okays Italfarmaco’s non-steroidal DMD therapy Duvyzat Italfarmaco’s oral HDAC inhibitor givinostat has been approved in the US as a treatment for Duchenne muscular dystrophy (DMD), becoming the first non-steroidal option for
News Reports: Makary out, Diamantas in as FDA commissioner According to multiple press reports citing anonymous insider sources, Dr Martin Makary has resigned after a year at the head of the FDA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
